Todd C. Davis - 21 Feb 2024 Form 4 Insider Report for Chromocell Therapeutics Corp (CHRO)

Role: Director
Signature: /s/ Todd Davis
Issuer symbol: CHRO
Transactions as of: 21 Feb 2024
Transactions value $: -$34,998
Form type: 4
Filing time: 23 Feb 2024, 17:15:39 UTC
Previous filing: 15 Feb 2024
Next filing: 29 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CHRO	Common Stock	Options Exercise	$140K	+29.2K		$4.80^*	29.2K	21 Feb 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CHRO	Secured Convertible Promissory Note	Conversion of derivative security	-$175K				0	21 Feb 2024	Common Stock	29.2K	$4.80	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the face amount of $175,000 this senior secured convertible promissory note, due February 29, 2024, which automatically converted into 29,167 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering, which is $6.00 per share.